Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by RIOU, B.
Right arrow Articles by VIARS, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by RIOU, B.
Right arrow Articles by VIARS, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 1995, Vol. 74, No. 4 424-429
© 1995 The Board of Management and Trustees of the British Journal of Anaesthesia


research-article

Cardiovascular consequences of severe hypophosphataemia in brain-dead patients{dagger}

B. RIOU, MD*, P. KALFON, MD, M. AROCK, MD, J.-P. GOARIN, MD, M. SAADA, MD and P. VIARS, MD

Department of Anesthesiology, CHU Pitié-Salpêtrière, Paris VI University Paris, France
Department of Biology for Emergencies, CHU Pitié-Salpêtrière, Paris VI University Paris, France

*Address for correspondence: Département d'Anesthésie-Réanimation, Groupe Hospitalier Pitié-Salpêtrière, 47 Boulevard de l'hôpital, 75651 Paris Cedex 13, Paris, France

Hypophosphataemia is known to induce reversible myocardial dysfunction, but the incidence of hypophosphataemia and its effect on myocardial function during brain death are unknown. In 90 consecutive brain-dead patients, we measured plasma concentrations of phosphate and left ventricular ejection fraction area (LVEFa), using transoesophageal echocardiography. In 15 severely hypophosphataemic (<0.40 mmol litre–1), consecutive, brain-dead patients, haemodynamic status, LVEFa, and oxygen delivery and consumption were assessed before and after phosphorus loading (0.30 mmol kg–1). In 10 other brain-dead patients, urine elimination of phosphates was measured. Only 30 (33%) brain-dead patients had normal plasma phosphate concentrations, 22 (24%) had mild hypophosphataemia (0.40–0.80 mmol litre–1) and 38 (42%) had severe hypophosphataemia (<0.40 mmol litre–1). There were no significant differences in LVEFa between these three groups (mean 53 (SD 16), 55 (12) and 51 (17)%, respectively) and no significant correlation between LVEFa and plasma phosphate concen tration (r = 0.04). In 15 severely hypophosphataemic patients, phosphorus loading increased plasma phosphate concentration from 0.30 (0.10) to 1.06 (0.41) mmol litre–1, but did not modify haemodynamic status, LVEFa or oxygen delivery and consumption. In 10 other patients, urine phosphorus elimination was 16.8 (23.3) mmol/ 24 h while plasma phosphate concentration was at its highest level (0.80 (0.37) mmol litre–1), and only one of these patient had a slightly elevated phosphaturia. In conclusion, hypophosphataemia frequently occurs after brain death but has no significant cardiovascular consequences, suggesting that it is related to intracellular transfer and not phosphorus depletion. Consequently, no significant improvement in myocardial function can be expected from phosphorus loading.

{dagger} Presented in part at the Annual Meeting of the American Society of Anesthesiologists, New Orleans, October 1992.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.